BIO-RAD LABORATORIES, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
BIO-RAD LABORATORIES, INC. (BIO) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $228.49 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2020-03-02
- BIO-RAD LABORATORIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2019-03-31 was $24.37M, a 7.55% increase year-over-year.
- BIO-RAD LABORATORIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2018-03-31 was $22.66M.
- BIO-RAD LABORATORIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2017-03-31 was -$164.58M.
- BIO-RAD LABORATORIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2019 was $228.49M, a 364.58% increase from fiscal 2018.
- BIO-RAD LABORATORIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2018 was $49.18M.
- BIO-RAD LABORATORIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2017 was -$72.19M.
- BIO-RAD LABORATORIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2016 was -$1.65M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2019-12-31 | $228.49M 10-K · filed 2020-03-02 | |||
| 2019-09-30 | $129.19M 10-Q · filed 2019-11-01 | |||
| 2019-06-30 | $149.20M 10-Q · filed 2019-08-06 | |||
| 2019-03-31 | $24.37M 10-Q · filed 2019-05-10 | |||
| 2018-12-31 | $49.18M 10-K · filed 2020-03-02 | |||
| 2018-09-30 | $50.61M 10-Q · filed 2019-11-01 | |||
| 2018-06-30 | $19.10M 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | $22.66M 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | -$72.19M 10-K · filed 2020-03-02 | |||
| 2017-09-30 | -$127.13M 10-Q · filed 2018-11-05 | |||
| 2017-06-30 | -$134.58M 10-Q · filed 2018-08-09 | |||
| 2017-03-31 | -$164.58M 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | -$1.65M 10-K · filed 2019-04-01 |